A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefilled auto-injector, or a vial with disposable syringe in healthy subjects

Peer Review reports

Original Submission
23 Jul 2019	Submitted	Original manuscript
23 Sep 2019	Reviewed	Reviewer Report - Yesim Tuncok
29 Sep 2019	Reviewed	Reviewer Report - Alfred Balch
14 Oct 2019	Author responded	Author comments - Jim Bush
Resubmission - Version 2
14 Oct 2019	Submitted	Manuscript version 2
4 Nov 2019	Reviewed	Reviewer Report - Alfred Balch
3 Dec 2019	Author responded	Author comments - Jim Bush
Resubmission - Version 3
3 Dec 2019	Submitted	Manuscript version 3
Publishing
4 Dec 2019	Editorially accepted
30 Dec 2019	Article published	10.1186/s40360-019-0376-9

Back to article page